|Programs + Specialties
|Training + Education
University of Vermont College of Medicine, San Francisco General Hospital, San Francisco, California
2018, Gail Anderson-Phil Manning Invited Lecture; Endocrine Disease in Pregnancy
2014, Appointed Inaugural Dierker-Biscotti Professor of Women’s Health and Wellness
2012, Macy Nigh-Whitener Professorship, Children’s Hospital Foundation, University of Oklahoma
2012, University of Toronto Charles H Best Lecture, for outstanding contributions to research in diabetes Toronto Canada
2012, University of Toronto, Henderson lecture, Dept. of Obstetrics and Gynecology
2011, Jorgen Pederson Lecturer, Diabetes in Pregnancy Study Group of the European Association for the Study of Diabetes
2011, March of Dimes Agnes Higgins Award, in Recognition of Service to the Cause of Improved Maternal Nutrition
2010, Elected by peers for inclusion in the “Best Doctors in America” from 2001-2012
Co-Chair of the NICHD Vision Workshop: pregnancy
2010, Group leader of the NICHD Vision Workshop; Developmental Origins of Health and Disease
2005, Distinguished Academic Achievement Award from the Medical Alumni Association of the University of Vermont College of Medicine in Burlington, VT
2004-2006, Chair, American Diabetes Association, Pregnancy and Women’s Health Council
2001-2012, Elected by peers for inclusion in the “Best Doctors in America”
2000, Norbert Freinkel Lecture Outstanding Research in the Field of Diabetes in Pregnancy
1997, President, Perinatal Research Society
1994, National Faculty Award for Excellence in Resident Education, Council on Resident Education in Obstetrics and Gynecology
1993, Department of Obstetrics and Gynecology, MetroHealth Medical Center, Teacher of the Year Award
1983 American College of Obstetrics and Gynecology Maternal Fetal Medicine Sam Seeds Research Fellowship Award
1982 Junior Fellow of American College of Obstetrics and Gynecology, Clinical Research Award Sponsored by Mead Johnson
1975 Moses Dyer Carbee Prize
For a complete list of Dr. Catalano's publications, see here: Full list
“Maternal Obesity and Fetal Programming: Long-term Consequences; Impact of Insulin Resistance and Glucose Metabolism on Pregnancy and Offspring Growth,” 24th International Congress of Gynecology and Obstetrics, Mexico City, June 25-28, 2019.
“Physiology of Pregnancy: Metabolic Adjustments” and Gestational Weight Gain: a Critical Appraisal of the IOM Guidelines.” Nutrition in Pregnancy, Lifelong Impact, Washington, DC, May 2-4, 2019.
“What Happens to Babies Born to Obese Mothers?” 66th Annual Scientific Meeting, Society for Reproductive Investigation, Satellite Symposium on Fetal Physiology, Paris, France, March 12-16, 2019.
“Maternal GDM and Obesity; short and long-term effects on the offspring,” Kaiser Permanente Division of Research, Oakland CA, October 16, 2018.
“Maternal Obesity and Metabolic Risk to the Offspring: Why Lifestyle interventions May Have Not Achieved the Desired Outcomes,” National Institutes of Health, Bethesda, MD, May 3, 2018.
“Hyperglycemia & Adverse Pregnancy Outcome (HAPO) Follow-up Study,” Annual Gail Anderson-Phil Manning Endocrine Disease in Pregnancy Lecture, USC-LAC, Los Angeles, CA, March 2, 2018.
“Introduction: What are the Big Questions,” Hot Topic Conference Obesity and Reproduction, Leuven, Belgium, November 9-10, 2017.
“Maternal Obesity in Pregnancy; Short and Long-Term Effects on the Offspring,” Grand Rounds, Department of Pediatrics, University of Texas Health Science Center at San Antonio (UTHSCSA), October 13, 2017.
“Maternal Pre-Pregnancy Metabolic Condition; Short and Long-term Effects on the Offspring,” 2017 Annual ONPRC Scientific Symposium Reproductive & Developmental Sciences: from Bench to Bedside, Beaverton, OR, September 22, 2017.
“When does post-delivery glucose metabolism improve in gestational diabetes (GDM) and does it relate to changes in cytokines/adipokines or lipids?” Waters T, Presley L, Hauguel de-Mouzon S, Catalano PM. DPSG, Nyborg, Denmark, September 7-10, 2017.
Patrick Catalano MD is a Professor and Vice Chair of Obstetrics and Gynecology at Tufts University School of Medicine and a Maternal -Fetal Medicine specialist at Tufts University Medical Center. His research is focused on maternal metabolism in women whose pregnancies are complicated by diabetes and obesity. Further he is studying the short and long-term effects on mothers and their children. He has had continuous funding from the Eunice Kennedy Shriver National Institutes of Child Health and Human Development for the past 30 year
Our research program is focused on a Lifestyle Intervention in Preparation for Pregnancy (LIPP). This is a RCT that is being conducted at Tufts Medical Center, the Pennington Biologic Research Center and Case Western Reserve University. The intervention is a lifestyle intervention of healthy eating (Mediterranean diet) and exercise to have overweight/obese subjects in the intervention group decrease their weight 5-7% based on pre-pregnancy weight from their prior pregnancy as compared to a control or usual care group. The Program in Boston will be conducted at Tufts Medical Center and the Human Nutrition Research Center on Aging (HNRCA). The study is funded by NICHD.
2019 – 2024
Blood Levels of Glycated CD59, a Novel Biomarker to Assess Pregnancy-induced Glucose Intolerance.
The overall goal of this proposal is to continue studies on plasma glycated CD59 (pGCD59) as a novel biomarker for gestational diabetes mellitus (GDM). Human studies indicate that pGCD59 is a sensitive biomarker of pregnancy-induced glucose intolerance1and is a molecular link between glycation inactivation of CD59 and the complications of GDM.
2019 – 2024
Kisspeptin: A novel Regulator of Insulin sensitivity in Pregnancy.
The goal of this project is to provide a comprehensive five-year training program for mentored career development in patient-oriented research for the PI, including independent clinical trials, specifically constructed to provide focused training pregnancy physiology and in the mechanisms of insulin physiology
Tufts Collaborative Grant
2019 – 2020
Infant feeding and early childhood adiposity: identifying targets for future intervention.
The overall goal is to investigate the relationship between maternal BMI, maternal infant feeding style and infant adiposity and to examine mediators or moderators of the maternal infant feeding style and infant adiposity relationship.
NIH/NICHD R01 HD091054
Placental Lipid Metabolism Impacts Fetal Adiposity and is Programmed by the Maternal Metabolic Milieu in Early Pregnancy.
Goals: To determine how maternal fat metabolism in early pregnancy programs placental lipid metabolism and neonatal fat deposition.
Level and Timing of Diabetic Hyperglycemia in utero: The Transgenerational Effect on Adult Morbidity (TEAM Study).
The objective of this proposal is to combine data from research conducted on a cohort of women with pregestational diabetes and follow-up of their offspring to elucidate the effect of exposure to hyperglycemia in utero on a spectrum of metabolic diseases and cardiovascular dysfunction.
NIH/NICHD R01 HD091735
Placental miRNA Profiles Associated with Maternal Insulin Resistance and Fetal Adiposity: Maternal-Placental Crosstalk.
Goals: To determine the association between miRNA originating in the placenta with maternal insulin resistance and fetal adiposity.
NIH/NICHD NIH HD 088061-01A1
Lifestyle Intervention in Preparation for Pregnancy. Click to view grant
The objective of this project is to break the vicious cycle of obesity/metabolic dysfunction during pregnancy to decrease the risk of maternal and neonatal perinatal morbidity. The primary aim is to decrease adiposity at birth in infants of overweight/obese women through lifestyle intervention of behavioral modification, healthy eating and exercise before a planned pregnancy using a RCT in women after their first pregnancy.
Role: Principal Investigator
NIH/NICHD NIH HD 079647
Comparison of Two Screening Strategies for Gestational Diabetes. The study will examine the current ACOG and IADPSG screening strategies for the diagnosis of gestational diabetes based on clinical outcomes. Outcomes include if either screening and treatment strategy results in healthier infants and mothers.
NIH/NIDDK NIH R8S119091
Hyperglycemia and Adverse Pregnancy Outcome-Follow up Study (HAPO-FUS).
The HAPO-FUS will evaluate the mothers who participated in the original HAPO study and their offspring at 8-12 years of age.
The purpose of the study is to evaluate maternal obesity and glucose tolerance during pregnancy as risk factors for metabolic dysfunction in the mother and her offspring.
Role: Principal Investigator at the MetroHealth site/Vice Chair Executive Committee